Cass Pharmaceuticals raises nearly $2 million
October 31, 2022 at 14:40 PM EDT
Founded in 2020, Franklin-based Cass aims to “create a future where effective and comprehensive treatment of diabetes is readily available and affordable,” according to the company’s website.
